Hamden, CT, United States of America

David Willner

This inventor holds 8 USPTO granted patents. Top assignees: Bristol-Myers Squibb Compnay, Bristol-Myers Company, Bristol-Myers Squibb. Active years: 1989-1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David Willner. Retrieved from https://idiyas.com/inventor/david-willner

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.3

ph-index = 6

Forward Citations = 565(Granted Patents)


Location History:

  • Dewitt, NY (US) (1989 - 1991)
  • Hamden, CT (US) (1992 - 1998)

Company Filing History:


Years Active: 1989-1998

Loading Chart...
8 patents (USPTO):Explore Patents

Title: David Willner: Innovator in Drug Development

Introduction

David Willner is a prominent inventor based in Hamden, CT (US). He has made significant contributions to the field of drug development, holding a total of 8 patents. His work focuses on creating innovative drug/ligand compounds that have the potential to impact medical treatments.

Latest Patents

One of David Willner's latest patents involves Thioether conjugates. This patent provides drug/ligand compounds of Formula (I), where D represents a drug moiety. His research in this area showcases his commitment to advancing pharmaceutical science.

Career Highlights

Throughout his career, David has worked with notable companies, including Bristol-Myers Squibb Company and Bristol-Myers Company. His experience in these organizations has allowed him to develop and refine his innovative ideas in drug development.

Collaborations

David has collaborated with esteemed colleagues such as Robert S. Greenfield and Gary R. Braslawsky. These partnerships have contributed to his success and the advancement of his research.

Conclusion

David Willner is a dedicated inventor whose work in drug development continues to influence the industry. His patents and collaborations reflect his expertise and commitment to innovation in pharmaceuticals.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…